Medpace Holdings Inc. (MEDP)
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts
Medpace (MEDP) reached $447.09 at the closing of the latest trading day, reflecting a +2.06% change compared to its last close.
Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript
Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript
Medpace Holdings: Great Quarter, Stale Backlog, Full Valuation
Medpace Holdings delivered strong Q4 and FY 2025 results, beating revenue and EPS expectations, with 32% YoY revenue growth and 27% YoY EPS growth. MEDP's backlog growth remains sluggish, but a healthy book-to-bill ratio and potential sector recovery could accelerate future growth. Valuation is now fair at ~32x P/E, with a DCF suggesting modest 6% upside; disciplined share buybacks continue to support EPS growth.
Medpace (MEDP) Beats Q4 Earnings and Revenue Estimates
Medpace (MEDP) came out with quarterly earnings of $4.67 per share, beating the Zacks Consensus Estimate of $4.18 per share. This compares to earnings of $3.67 per share a year ago.
Medpace (MEDP) Declines More Than Market: Some Information for Investors
In the most recent trading session, Medpace (MEDP) closed at $582.48, indicating a -1.79% shift from the previous trading day.
Why the Market Dipped But Medpace (MEDP) Gained Today
Medpace (MEDP) closed at $616.45 in the latest trading session, marking a +1.32% move from the prior day.
Medpace (MEDP) Stock Dips While Market Gains: Key Facts
Medpace (MEDP) closed the most recent trading day at $600.02, moving 2.13% from the previous trading session.
Why Medpace (MEDP) Dipped More Than Broader Market Today
In the most recent trading session, Medpace (MEDP) closed at $561.65, indicating a -1.27% shift from the previous trading day.
Medpace (MEDP) Outperforms Broader Market: What You Need to Know
In the latest trading session, Medpace (MEDP) closed at $568.36, marking a +1.45% move from the previous day.
Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?
Here is how Medpace (MEDP) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
Medpace (MEDP) Upgraded to Strong Buy: What Does It Mean for the Stock?
Medpace (MEDP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
